Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
This study is currently recruiting participants.
Verified August 2012 by Kyowa Hakko Kirin Pharma, Inc.
Sponsor:
Kyowa Hakko Kirin Pharma, Inc.
Collaborator:
Teva Pharma
Information provided by (Responsible Party):
Kyowa Hakko Kirin Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT01447732
First received: September 30, 2011
Last updated: August 21, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |